Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

With an aim to develop affordable, top quality culture media for reducing cost of monoclonal antibodies (mAbs) in India, the Mumbai-based HiMedia Laboratories, a leading biosciences company, is set to ...

After the safety and efficacy of a biopharmaceutical, the efficiency of bioprocessing it might be the most crucial aspect. As Aleksandr Pogodaev, PhD—principal scientist in pharmacometrics, Novartis ...

Therapeutic antibodies will always be too expensive for low- and middle-income countries, unless manufacturers embrace more cost-efficient production tech. So says Peter Gardner, scientific director ...